Search

Your search keyword '"Shah, P."' showing total 1,698 results

Search Constraints

Start Over You searched for: Author "Shah, P." Remove constraint Author: "Shah, P." Database Unpaywall Remove constraint Database: Unpaywall
1,698 results on '"Shah, P."'

Search Results

6. Cell-Free DNA Exposes Tissue Injury Profiles Leading to Primary Graft Dysfunction

7. Rationale, Design and Patient Characteristics from The DevelopmEnt of Non-Invasive Cell-Free DNA to Supplant INvasivE Biopsy in Heart Transplantation (DEFINE-HT) Study

9. Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation

12. Defining Optimal Criteria for LVAD Weaning in HF Patients with an Improvement in Cardiac Structure and Function: A VAD Wean Registry Analysis

14. The Role of Cardiopulmonary Exercise Testing for Predicting Outcomes After LVAD Weaning, a VAD Wean Registry Study

15. Early Posttransplant Bronchoalveolar Lavage Fluid (BALF) Hyaluronan is an Independent Risk Marker for Chronic Lung Allograft Dysfunction (CLAD)

16. Predictive Model of the Sustainability of Favorable Response After LVAD Weaning in HF Patients: A VAD Wean Registry Analysis

17. International Multicenter Report on Long Term Outcomes After LVAD Weaning: The VAD Wean Registry

18. Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve Post-LVAD Reverse Cardiac Remodeling

19. A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death

22. Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients

23. Cell-Free DNA to Unveil Potential Mechanisms of Racial Disparities in Lung Transplant

26. Molecular subtyping for predicting non-organ confined disease and survival outcomes after radical cystectomy in clinical high-grade T1 and T2 bladder cancer patients

32. Survival following lung volume reduction procedures: results from the UK Lung Volume Reduction (UKLVR) registry

34. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

36. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

37. Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers

38. Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial

41. Long COVID research: an update from the PHOSP-COVID Scientific Summit

43. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

49. Efficacy of etrasimod at Week 52 among patients with clinical response at Week 12 compared with the overall ulcerative colitis population: post hoc analysis of the phase 3 ELEVATE UC 52 trial

50. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Catalog

Books, media, physical & digital resources